XML 47 R24.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Business Segments
12 Months Ended
Jun. 30, 2024
Business Segments  
Business Segments

16. Business Segments

We evaluate performance and allocate resources based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to a segment or segments and we refer to these items as Corporate. We do not allocate Corporate costs or assets to the other segments because they are not used to evaluate the segments’ operating results or financial position. Corporate costs include certain costs related to executive management, information technology, legal, finance, human resources and business development. The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein.

We evaluate performance of our segments based on Adjusted EBITDA. We calculate Adjusted EBITDA as net income plus (a) interest expense, net, (b) provision for income taxes or less benefit for income taxes, (c) depreciation and amortization, (d) other expense or less other income, as separately reported on our consolidated statements of operations,

including foreign currency (gains) losses, net and (e) certain items that we consider to be unusual, non-operational or non-recurring.

For the Year Ended June 30

2024

2023

2022

Net sales

 

  

 

  

 

  

Animal Health

$

706,482

$

659,851

$

607,055

Mineral Nutrition

 

243,663

 

242,656

 

259,512

Performance Products

 

67,534

 

75,382

 

75,694

Total segments

$

1,017,679

$

977,889

$

942,261

Depreciation and amortization

Animal Health

$

30,194

$

27,714

$

26,759

Mineral Nutrition

 

2,427

 

2,638

 

2,616

Performance Products

 

1,688

 

1,780

 

1,717

Total segments

$

34,309

$

32,132

$

31,092

Adjusted EBITDA

Animal Health

$

145,606

$

136,139

$

124,106

Mineral Nutrition

 

16,449

 

17,417

 

24,038

Performance Products

 

7,662

 

9,346

 

8,706

Total segments

$

169,717

$

162,902

$

156,850

Reconciliation of income before income taxes to Adjusted EBITDA

Income before income taxes

$

10,916

$

54,071

$

72,327

Interest expense, net

 

18,536

 

15,321

 

11,875

Depreciation and amortization – Total segments

 

34,309

 

32,132

 

31,092

Depreciation and amortization – Corporate

 

1,869

 

1,880

 

1,613

Corporate costs

58,480

50,149

45,767

Acquisition-related cost of goods sold

 

521

 

 

316

Acquisition-related transaction costs

 

6,405

 

 

279

Pension settlement cost

10,674

Brazil employment taxes

4,202

Stock-based compensation

 

475

 

 

Phibro Forward income growth initiatives implementation costs

366

Insurance proceeds

(899)

Environmental remediation costs

6,894

Gain on sale of investment

(1,203)

Foreign currency (gains) losses, net

 

23,863

 

2,455

 

(5,216)

Adjusted EBITDA – Total segments

$

169,717

$

162,902

$

156,850

 

As of June 30

    

2024

    

2023

Identifiable assets

 

  

 

  

Animal Health

$

684,407

$

698,522

Mineral Nutrition

 

67,088

 

75,814

Performance Products

 

50,862

 

49,678

Total segments

 

802,357

 

824,014

Corporate

 

179,827

 

147,383

Total

$

982,184

$

971,397

 

The Animal Health segment includes all goodwill of the Company. Corporate assets include cash and cash equivalents, short-term investments, debt issuance costs, income tax related assets and certain other assets.

The geographic location of property, plant and equipment, net was:

As of June 30

    

2024

    

2023

Property, plant and equipment, net

 

  

 

  

United States

$

87,526

$

79,404

Israel

 

60,395

 

61,304

Brazil

 

30,348

 

30,359

Ireland

19,038

18,900

Other

 

5,993

 

5,601

$

203,300

$

195,568